KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medtronic (MDT) Capital Expenditures (2016 - 2025)

Historic Capital Expenditures for Medtronic (MDT) over the last 12 years, with Q4 2025 value amounting to $468.0 million.

  • Medtronic's Capital Expenditures rose 1584.16% to $468.0 million in Q4 2025 from the same period last year, while for Oct 2025 it was $1.9 billion, marking a year-over-year increase of 1244.1%. This contributed to the annual value of $1.9 billion for FY2025, which is 1713.93% up from last year.
  • According to the latest figures from Q4 2025, Medtronic's Capital Expenditures is $468.0 million, which was up 1584.16% from $504.0 million recorded in Q3 2025.
  • In the past 5 years, Medtronic's Capital Expenditures registered a high of $520.0 million during Q3 2024, and its lowest value of $271.0 million during Q4 2021.
  • Moreover, its 5-year median value for Capital Expenditures was $383.5 million (2021), whereas its average is $399.2 million.
  • Per our database at Business Quant, Medtronic's Capital Expenditures crashed by 1690.14% in 2023 and then skyrocketed by 4689.27% in 2024.
  • Medtronic's Capital Expenditures (Quarter) stood at $271.0 million in 2021, then increased by 19.19% to $323.0 million in 2022, then skyrocketed by 42.72% to $461.0 million in 2023, then dropped by 12.36% to $404.0 million in 2024, then increased by 15.84% to $468.0 million in 2025.
  • Its last three reported values are $468.0 million in Q4 2025, $504.0 million for Q3 2025, and $459.0 million during Q2 2025.